Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,612.00
Bid: 1,613.00
Ask: 1,614.00
Change: 12.00 (0.75%)
Spread: 1.00 (0.062%)
Open: 1,608.00
High: 1,619.00
Low: 1,604.50
Prev. Close: 1,600.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bird flu testing shows more dairy products are safe, US FDA says

Wed, 01st May 2024 19:39

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

The FDA released further test results on foods including sour cream and cottage cheese, after reporting last week that preliminary results from testing showed pasteurization kills the H5N1 virus in milk and baby formula.

The U.S. Department of Agriculture (USDA) has confirmed bird flu in 36 dairy herds in nine states since the first-ever detection in late March, though scientists have said the outbreak is likely more widespread based on findings of H5N1 particles in about 20% of milk samples. One Texas dairy worker tested positive for the virus.

The USDA believes the virus is spreading among cattle primarily through contact with raw milk, Rosemary Sifford, the agency's chief veterinary officer, said on a call that also included officials from the FDA and U.S. Centers for Disease Control and Prevention (CDC). Cows shed the virus at high concentrations in milk, the USDA said.

The FDA so far has tested 297 total retail samples of pasteurized dairy products, and the results released on Wednesday represent tests on 201 of those samples.

"It is a pretty good body of results," Donald Prater, acting director of the FDA's Center for Food Safety and Applied Nutrition, said on the call. "There are probably a few more products that we would look at just so that we make sure that we've got a good national sample."

Scientists are on alert for changes in H5N1 that could signal the virus is adapting to spread easily among humans. The virus has caused serious or fatal infections among people in close contact with wild birds or poultry. It has long been on the list of viruses with pandemic potential, and any expansion to a new mammal species is concerning.

CDC official Dr. Demetre Daskalakis said the agency has monitored about 100 people who have been exposed to bird flu, and around 25 people who developed symptoms have been tested. So far, no additional positive cases have been found.

The agency tested a sample of the virus taken from the farm worker who was infected with H5N1 and found that all commercially available antiviral flu treatments are effective against it. The worker's only symptom was conjunctivitis, commonly known as pink eye.

Currently approved antiviral drugs include Roche's Xofluza and Tamiflu as well as a generic version of Tamiflu, GSK's Relenza and BioCryst Pharmaceuticals' Rapivab.

The CDC said it is working to grow virus from the infected farm worker for additional lab experiments to assess the severity of the illness and transmissibility of the virus.

It said disease monitoring shows no unusual flu activity in people.

The USDA is testing retail samples of ground beef but said results are not yet available. The department has said it is confident the meat supply is safe.

Wild birds that carry the virus appear to be the initial source of infections in dairy cows, according to USDA. Movement of cattle then spread the disease to other herds and subsequently into poultry flocks, the agency said. (Reporting by Julie Steenhuysen and Tom Polansek; Writing by Caroline Humer; Editing by Bill Berkrot)

More News
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.